Feiba NF 1300 Unit

FEIBA NF 1300 Unit is an anti-inhibitor coagulant complex used for managing bleeding episodes in patients with hemophilia. This intravenous kit from Takeda Canada Inc. helps support clotting in specific medical conditions.

FEIBA NF 1300 Unit is primarily used to manage bleeding episodes in patients with hemophilia who have developed inhibitors. These inhibitors can interfere with the effectiveness of standard clotting treatments. The anti-inhibitor coagulant complex works by providing clotting factors that bypass the inhibitors, helping to control bleeding. It is often used in situations where other treatments are not effective.

Common effects of FEIBA NF 1300 Unit may include localized reactions at the injection site, such as redness or swelling. Some users might experience mild fever or chills. Severe allergic reactions are rare but possible and require immediate medical attention.

FEIBA NF 1300 Unit should be administered under medical supervision. It is important to inform healthcare providers about any allergies or pre-existing conditions before use. Proper storage and handling are crucial to maintain the effectiveness of the product. Always follow the guidelines provided by healthcare professionals.

FEIBA NF 1300 Unit may interact with other medications, particularly those that affect blood clotting. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of the treatment.